Home » Baxter to Acquire Investigational Hemophilia Compound and Related Assets
Baxter to Acquire Investigational Hemophilia Compound and Related Assets
Baxter International has entered into an agreement to acquire Inspiration BioPharmaceuticals’ investigational hemophilia compound OBI-1 and related assets.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May